WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004004722) 1-AMIDO-4-PHENYL-4-BENZYLOXYMETHYL-PIPERIDINE DERIVATIVES AND RELATED COMPOUNDS AS NEUROKININ-1(NK-1) ANTAGONISTS FOR THE TREATMENT OF EMESIS, DEPRESSION, ANXIETY AND COUGH
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/004722    International Application No.:    PCT/US2003/020783
Publication Date: 15.01.2004 International Filing Date: 02.07.2003
Chapter 2 Demand Filed:    27.01.2004    
IPC:
C07D 211/98 (2006.01), C07D 401/04 (2006.01), C07D 401/12 (2006.01), C07D 405/12 (2006.01), C07D 409/12 (2006.01), C07D 413/04 (2006.01), C07D 413/12 (2006.01), C07D 417/12 (2006.01), C07D 417/14 (2006.01)
Applicants: SCHERING CORPORATION [US/US]; 2000 Galloping Hill Road, Kenilworth, NJ 07033-0530 (US)
Inventors: SHIH, Neng-Yang; (US).
WANG, Steven; (US).
REICHARD, Gregory, A.; (US).
XIAO, Dong; (US).
WANG, Cheng; (US)
Priority Data:
60/393,708 03.07.2002 US
Title (EN) 1-AMIDO-4-PHENYL-4-BENZYLOXYMETHYL-PIPERIDINE DERIVATIVES AND RELATED COMPOUNDS AS NEUROKININ-1(NK-1) ANTAGONISTS FOR THE TREATMENT OF EMESIS, DEPRESSION, ANXIETY AND COUGH
(FR) DERIVES DE 1-AMIDO-4-PHENYL-4-BENZYLOXYMETHYL-PIPERIDINE ET COMPOSES ASSOCIES EN TANT QU'ANTAGONISTES DE LA NEUROKININE-1(NK-1) DANS LE TRAITEMENT DES VOMISSEMENTS, DE LA DEPRESSION, DE L'ANGOISSE ET DE LA TOUX
Abstract: front page image
(EN)Disclosed are NK1 antagonists having the formula: Also disclosed are uses of compounds of formula (I) for the manufacture of a medicament for treating a number of physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.
(FR)L'invention concerne des antagonistes de NK1 ayant la formule (I). L'invention concerne également les utilisations de composés de la formule (I) dans la fabrication d'un médicament destiné au traitement d'un certain nombre de troubles, symptômes ou maladies physiologiques parmi lesquels les vomissements, la dépression, l'angoisse et la toux.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, HR, HU, ID, IL, IN, IS, JP, KG, KR, KZ, LC, LK, LR, LT, LU, LV, MA, MD, MG, MK, MN, MX, MZ, NI, NO, NZ, PG, PH, PL, PT, RO, RU, SC, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UZ, VC, VN, YU, ZA, ZM.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)